• linkedin
  • Increase Font
  • Sharebar

    Urology-specific quality measures are coming

    Measures help urologists report on prostate, bladder Ca care

     

    Two quality measures developed

    The first quality measure, which will mandate a bone-density screening for men who are being prescribed androgen-deprivation therapy with the intent to treat for a year or greater, has been approved by the Centers for Medicare & Medicaid Services (CMS) and will take effect Jan. 1, 2018. The bone density screening has to occur prior to the ADT or within 3 months of initiation.

    Read - Burnout: How can it be prevented?

    The second, mandating BCG treatment for those with high-grade nonmuscle-invasive bladder cancer, will take effect the following year.

    “eClinical Quality Measures are vitally important to maintaining quality of care, and they reflect a commitment from LUGPA and its members to pursue best practices that consistently advance the practice of urology,” Dr. Mehlhaff said.

    Now, additional measures are expected to be developed by LUGPA for the treatment of osteopenia or osteoporosis in men with non-metastatic prostate cancer who are on androgen-deprivation therapy, for International Prostate Symptom Score or AUA Symptom Index change 6-12 months after diagnosis of BPH, and for the use of active surveillance for low-risk prostate cancer patients.

    All of these eClinical Quality Measures will be available for use by all urologists, according to Dr. Mehlhaff and Colleen Parker, RN, also of the Oregon Urology Institute, who did the majority of the heavy lifting to get the initial two measures developed in conjunction with a panel of technical experts.

    Also see: Burnout rate lower than believed, but still too high

    “We’re designing these measures for all of urology, and we have to get it right,” Dr. Mehlhaff declared.

    Next: How the measures work

    Bob Gatty
    Bob Gatty, a former congressional aide, covers news from Washington for Urology Times.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results